EMEA-000026-PIP02-11
Key facts
Invented name |
Torisel
|
Active substance |
Temsirolimus
|
Therapeutic area |
Oncology
|
Decision number |
P/262/2011
|
PIP number |
EMEA-000026-PIP02-11
|
Pharmaceutical form(s) |
Concentrate and diluent for solution for infusion
|
Condition(s) / indication(s) |
Treatment of mantle cell lymphoma
|
Route(s) of administration |
Intravenous use
|
Contact for public enquiries |
Pfizer Limited
|
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|